Fasting plasma ghrelin concentrations 6 months after gastric bypass are not determined by weight loss or changes in insulinemia.
about
Recent advances in metabolic and bariatric surgeryMechanism Underlying the Weight Loss and Complications of Roux-en-Y Gastric Bypass. ReviewDevelopment of minimally invasive techniques for management of medically-complicated obesityGhrelin and eating disordersThe neurohormonal regulation of energy intake in relation to bariatric surgery for obesityChanges in neurohormonal gut peptides following bariatric surgery.Obese subjects respond to the stimulatory effect of the ghrelin agonist growth hormone-releasing peptide-2 on food intakeSuperior appetite hormone profile after equivalent weight loss by gastric bypass compared to gastric bandingGhrelin and metabolic surgery.Could the improvement of obesity-related co-morbidities depend on modified gut hormones secretion?Changes in gastrointestinal hormones and leptin after Roux-en-Y gastric bypass procedure: a reviewImpact of sustained weight loss achieved through Roux-en-Y gastric bypass or a lifestyle intervention on ghrelin, obestatin, and ghrelin/obestatin ratio in morbidly obese patientsMechanisms responsible for excess weight loss after bariatric surgeryBariatric surgery for extreme adolescent obesity: indications, outcomes, and physiologic effects on the gut-brain axisRole of Gut-Related Peptides and Other Hormones in the Amelioration of Type 2 Diabetes after Roux-en-Y Gastric Bypass Surgery.Physiology of weight loss surgery.Therapy insight: weight-loss surgery and major cardiovascular risk factors.Obesity and the role of gut and adipose hormones in female reproduction.Association of ghrelin receptor promoter polymorphisms with weight loss following Roux-en-Y gastric bypass surgeryCatalytic antibody degradation of ghrelin increases whole-body metabolic rate and reduces refeeding in fasting miceCritical assessment of the current guidelines for the management and treatment of morbidly obese patients.The effect of laparoscopic gastric banding surgery on plasma levels of appetite-control, insulinotropic, and digestive hormonesEffect of various treatments on leptin, adiponectin, ghrelin and neuropeptide Y in patients with type 2 diabetes mellitus.Roux-en-Y gastric bypass and laparoscopic sleeve gastrectomy: understanding weight loss and improvements in type 2 diabetes after bariatric surgery.Metabolic surgery-principles and current concepts.Timeline of changes in appetite during weight loss with a ketogenic diet.Changes in Fasting and Prandial Gut and Adiposity Hormones Following Vertical Sleeve Gastrectomy or Roux-en-Y-Gastric Bypass: an 18-Month Prospective Study.Gastrojejunal anastomotic reduction for weight regain in roux-en-y gastric bypass patients: physiological, behavioral, and anatomical effects of endoscopic suturing and sclerotherapy.Potential Hormone Mechanisms of Bariatric Surgery.The Impact of Ghrelin in Metabolic Diseases: An Immune PerspectiveAmelioration of glycemic control by sleeve gastrectomy and gastric bypass in a lean animal model of type 2 diabetes: restoration of gut hormone profile.Plasma Ghrelin Levels and Weight Regain After Roux-en-Y Gastric Bypass Surgery.Changes in metabolic hormones after bariatric surgery and their predictive impact on weight loss.Food aversions in women during the 2 years after Roux-en-Y gastric bypass.Long-term changes in leptin, chemerin and ghrelin levels following different bariatric surgery procedures: Roux-en-Y gastric bypass and sleeve gastrectomy.Gastric bypass surgery may improve beta cell apoptosis with ghrelin overexpression in patients with BMI ≥ 32.5 kg/m(2.).Effects of laparoscopic gastric band applications on plasma and fundic acylated ghrelin levels in morbidly obese patients.Meal suppression of circulating ghrelin is normalized in obese individuals following gastric bypass surgery.Evaluation of leptin, adiponectin, and ghrelin levels in patients with acne vulgaris.
P2860
Q26745203-29A8EF67-3AF3-4AAB-AFF9-D2BB2A8E563EQ26780440-C5A22AB1-50C8-420C-951D-E661764B7644Q26851369-FEEFB545-DFC8-4D4A-B966-02AE9425ACC0Q26995199-DB73DFB1-3EBD-455E-96B5-ACD425132FF2Q30388925-B70DB628-BA6C-4BDF-BDBB-E6A09D1121D2Q30391329-98BEB145-56D8-457E-903B-050EA0297AF8Q33669320-74EC9325-7349-4CB3-9B36-C9C1F3F03AE2Q33879265-21ABF7CB-F3F4-41B2-ACF5-6AECEF9BA939Q34026487-EB509E2E-31A7-49D5-9060-4C38BB9C7BA1Q34589770-113313DE-5344-4935-8579-0FDD45EA2169Q34824005-8BD65851-3552-408A-9AE2-35CF28880134Q34981837-E6C727DB-1766-47D6-9850-1CC3C2C3597BQ35529693-21C58355-38C5-4490-AD2F-EBBFC7F66E49Q35677192-C89A2049-42F3-4E12-AEA9-9C5E30AE0824Q35963032-925CF841-2C1B-49F0-BC2D-C5FCF59DEC78Q36055375-E4F32163-21F4-4CA6-8689-4D94671838BAQ36301144-041D889A-F6FF-4B12-9172-A23D2442D04BQ36507088-D44288BA-2D07-461A-96BA-4D6C0C7C6823Q36533912-D8C939C3-28F6-45EA-A891-0F6C9EC88A5CQ36970993-E6021812-5CEF-4EF6-A972-4B857A9675C2Q37030446-45BC3CF2-7220-479C-AD8E-C1ABBFEAEF7CQ37095586-CEFFA41C-140C-4D8D-BD68-8E7BD1EBF0E6Q37831911-BFB9F138-2F0C-4A37-A742-BBD56AA1E5E3Q37862878-B7C4D8C2-B4CE-4573-9431-1EA942E11D5CQ37922651-C7AB887D-A326-4D20-A2A9-593C04599667Q38821968-4DBBF024-FD2B-4FA3-A867-2AEE9D593C26Q39076089-C227BF81-1020-40BF-9F6B-ED30D4A9E0F1Q39081774-EBDE01C2-2849-4A0D-B53C-27EC8E564C8CQ41625381-35056C76-71E8-4324-A890-FD1C863387F3Q42730636-CA99E290-4904-45DF-B1E3-BDE3BBFA75BEQ43499924-A764C6CE-E965-4FDD-B435-5862D87A1B83Q47251194-46F86BA3-B705-4C04-ACFE-9F5C15420A8DQ47287964-0B82FE5C-2D22-47E1-95DB-FF28BF106B05Q50549765-80991C54-418F-4A33-AE6E-B390E0820630Q50853632-A473FBC3-9013-4C59-95E0-B35420C96082Q51330636-B9C02EAC-D77A-47A5-B0A3-B9CB5F261D7FQ51369049-5D93FE0D-6DC9-4922-9D10-F32F6A0AAD36Q51491650-DAFC2A0C-5D04-449E-97C2-221865D013A2Q53798124-318EF15E-ED0B-431B-8991-D20D3424DA46
P2860
Fasting plasma ghrelin concentrations 6 months after gastric bypass are not determined by weight loss or changes in insulinemia.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年学术文章
@wuu
2004年学术文章
@zh
2004年学术文章
@zh-cn
2004年学术文章
@zh-hans
2004年学术文章
@zh-my
2004年学术文章
@zh-sg
2004年學術文章
@yue
2004年學術文章
@zh-hant
name
Fasting plasma ghrelin concent ...... oss or changes in insulinemia.
@en
Fasting plasma ghrelin concent ...... oss or changes in insulinemia.
@nl
type
label
Fasting plasma ghrelin concent ...... oss or changes in insulinemia.
@en
Fasting plasma ghrelin concent ...... oss or changes in insulinemia.
@nl
prefLabel
Fasting plasma ghrelin concent ...... oss or changes in insulinemia.
@en
Fasting plasma ghrelin concent ...... oss or changes in insulinemia.
@nl
P2093
P50
P356
P1433
P1476
Fasting plasma ghrelin concent ...... oss or changes in insulinemia.
@en
P2093
Fernando Rotellar
Javier Salvador
José Luis Hernández-Lizoain
M Jesús Gil
P2888
P304
P356
10.1381/0960892042386904
P577
2004-10-01T00:00:00Z
P6179
1021889464